IL-3 is a novel target to interfere with tumor vasculature
Por um escritor misterioso
Descrição
Senescent T cells: a potential biomarker and target for cancer therapy - eBioMedicine
Platelet-Membrane-Coated Nanoparticles Enable Vascular Disrupting Agent Combining Anti-Angiogenic Drug for Improved Tumor Vessel Impairment
Checkpoint blockade to overcome acquired resistance to immunocytokine
Frontiers Molecules promoting circulating clusters of cancer cells suggest novel therapeutic targets for treatment of metastatic cancers
Frontiers Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies
Targeting the tumor stroma for cancer therapy, Molecular Cancer
Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy
Frontiers Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer
Tweak to Treat: Reprograming Bacteria for Cancer Treatment: Trends in Cancer
Integrin-mediated cancer progression as a specific target in clinical therapy - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)
